Pharmacological Treatment of Acute Psychiatric Symptoms in COVID-19 Patients: A Systematic Review and a Case Series.
COVID-19 (coronavirus disease 2019)
SARS-CoV-2
acute psychosis
delirium
psychomotor agitation
restlessness
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
20 04 2022
20 04 2022
Historique:
received:
05
01
2022
revised:
10
04
2022
accepted:
12
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
Delirium and psychomotor agitation are relevant clinical conditions that may develop during COVID-19 infection, especially in intensive care unit (ICU) settings. The psychopharmacological management of these conditions is receiving increasing interest in psychiatry, considering hyperkinetic delirium as one of the most common neuropsychiatries acute consequences in COVID-19 recovery patients. However, there are no actual internationally validated guidelines about this topic, due to the relatively newly introduced clinical condition; in addition, a standardized psychopharmacologic treatment of these cases is a complex goal to achieve due to the risk of both drug-drug interactions and the vulnerable conditions of those patients. The aim of this systematic review and case series is to evaluate and gather the scientific evidence on pharmacologic handling during delirium in COVID-19 patients to provide practical recommendations on the optimal management of psychotropic medication in these kinds of patients. The electronic databases PubMed, Embase and Web of Science were reviewed to identify studies, in accordance with the PRISMA guidelines. At the end of the selection process, a total of 21 studies (
Identifiants
pubmed: 35564372
pii: ijerph19094978
doi: 10.3390/ijerph19094978
pmc: PMC9099660
pii:
doi:
Substances chimiques
Psychotropic Drugs
0
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Références
SN Compr Clin Med. 2021;3(7):1627-1629
pubmed: 33997622
Intensive Care Med. 2020 Apr;46(4):576-578
pubmed: 32077996
ACS Chem Neurosci. 2020 May 20;11(10):1495-1503
pubmed: 32364698
Front Psychiatry. 2020 Dec 03;11:580736
pubmed: 33343419
Ther Adv Psychopharmacol. 2020 Jul 20;10:2045125320942703
pubmed: 32733668
J Hosp Med. 2010 Apr;5(4):E8-16
pubmed: 20394022
BMJ Open. 2021 Sep 17;11(9):e050045
pubmed: 34535480
J Clin Psychiatry. 2000;61 Suppl 14:5-10
pubmed: 11154018
Drugs. 2005;65(9):1207-22
pubmed: 15916448
Cureus. 2020 Dec 9;12(12):e11993
pubmed: 33437548
Mayo Clin Proc. 2012 Oct;87(10):982-90
pubmed: 22877654
Clin Case Rep. 2021 Mar 11;9(4):2285-2288
pubmed: 33936680
BMJ Case Rep. 2020 Oct 31;13(10):
pubmed: 33130587
J Clin Pharmacol. 2001 Dec;41(12):1310-8
pubmed: 11762558
Front Psychiatry. 2021 Oct 15;12:726059
pubmed: 34721104
Psychosomatics. 2020 Nov - Dec;61(6):585-596
pubmed: 32828569
J Affect Disord. 2020 Sep 1;274:1062-1067
pubmed: 32663933
Crit Care Nurs Q. 2017 Oct/Dec;40(4):344-362
pubmed: 28834857
Psychiatry Res. 2021 Nov;305:114245
pubmed: 34678522
Crit Care Med. 2016 Jul;44(7):1295-306
pubmed: 26925523
Psychiatr Q. 2021 Sep;92(3):1021-1033
pubmed: 33411128
BMJ Case Rep. 2021 Nov 1;14(11):
pubmed: 34725060
J Acad Consult Liaison Psychiatry. 2021 Jan-Feb;62(1):109-114
pubmed: 33069380
Psychosomatics. 2020 Sep - Oct;61(5):544-550
pubmed: 32591212
Viruses. 2019 Dec 20;12(1):
pubmed: 31861926
J Psychiatr Pract. 2021 Mar 5;27(2):131-136
pubmed: 33656820
Expert Opin Drug Saf. 2003 Nov;2(6):543-7
pubmed: 14585064
Neurochem Res. 2014 Oct;39(10):2008-17
pubmed: 24682754
Heart Lung. 2018 Nov;47(6):591-601
pubmed: 30266265
Am J Geriatr Psychiatry. 1997 Winter;5(1):60-9
pubmed: 9169246
JAMA. 2020 May 19;323(19):1897-1898
pubmed: 32208486
Front Psychiatry. 2020 Nov 12;11:586686
pubmed: 33262713
Crit Care Med. 2014 Feb;42(2):369-77
pubmed: 24158172
JAMA. 2004 Apr 14;291(14):1753-62
pubmed: 15082703
Cureus. 2021 Feb 18;13(2):e13428
pubmed: 33763319
BMJ Case Rep. 2020 Jun 14;13(6):
pubmed: 32540882
Psychiatry Res. 2020 Oct;292:113312
pubmed: 32717711
Asian J Psychiatr. 2021 Jan;55:102513
pubmed: 33360706
Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004990
pubmed: 15495135
Int J Psychiatry Med. 2021 Jul;56(4):255-265
pubmed: 33517809
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Gen Hosp Psychiatry. 2020 Jul - Aug;65:47-53
pubmed: 32470824
Eur J Psychiatry. 2021 Jul-Sep;35(3):197-199
pubmed: 33518880
BMJ Evid Based Med. 2018 Apr;23(2):60-63
pubmed: 29420178
West J Emerg Med. 2012 Feb;13(1):26-34
pubmed: 22461918
IDCases. 2021;24:e01140
pubmed: 33936950
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
BMC Med. 2020 Jul 15;18(1):215
pubmed: 32664944
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Brain Sci. 2021 Oct 26;11(11):
pubmed: 34827412
Neurol Sci. 2021 Oct;42(10):3981-3988
pubmed: 34318364